NHOA
23.7.2021 07:02:13 CEST | Business Wire | Press release
Regulatory News:
In the context of the Masterplan10x and the Strategic Ambitions released by NHOA (Paris:NHOA) on the date hereof, and of the approval of the Board of Directors of Free2Move eSolutions, Carlalberto Guglielminotti, NHOA’s Chief Executive Officer and Executive Chairman of Free2Move eSolutions, announces the project to develop the first electric vehicle fastcharging network 100% vehicle-to-grid integrated (VGI), enabled by renewables and energy storage (the “Atlante Project ”). The Atlante Project is also timely in the context of the adoption by the European Commission, on July 14 2021, of the Fit for 55 package whose aims are, among others, having 100% zero-emission cars registered as of 2035 and installing charging and fuelling points at regular intervals on major highways: every 60 kilometres for electric charging and every 150 kilometres for hydrogen refuelling.
The Atlante Project will be initially developed in Southern Europe and, as announced during the Stellantis EV Day 2021 on July 8, 2021, will be an open network and will cater to the demands of the varied customers of Stellantis, being the preferred fastcharging network of Stellantis and its customers (the “Atlante Network ”).
NHOA will develop and invest in the Atlante Network as owner and operator, with its own resources and other forms of financing including among others, TCC’s support as key founding investor, and Free2Move eSolutions will act as turn-key technology provider.
“The Atlante Project is the cornerstone of our Strategic Ambitions and a testament to the new transformational business model of NHOA: from a pure technology player to an infrastructure developer, owner and operator that fully leverages on a complete product portfolio and vertically integrated technology in both Storage and eMobility, ” said Carlalberto Guglielminotti, Chief Executive Officer of NHOA and Executive Chairman of Free2Move eSolutions.
Roberto di Stefano, Chief Executive Officer of Free2Move eSolutions commented, “Atlante is opening a new era where the energy transition and the Zero Emission Mobility will become the normality on our life allowing a better Planet for future generations. ”
The market potential, perimeter and ambitions of the Atlante Project have been defined by NHOA and Free2Move eSolutions having regard to the market analyses prepared by McKinsey & Co.
Market outlook and 2-step Roadmap to 2030
The Southern European public fastcharging market, namely Italy, France, Spain and Portugal (“Core Countries ”), is still nascent with rapid growth expected towards 2030. Around 90% of 2030 Southern European on-the-go fastcharging network is yet to be built and developed and this constitutes a great potential business opportunity.
In particular, according to the analysis carried out by NHOA and Free2Move eSolutions with the support of McKinsey & Co: (i) the battery electric vehicle (BEV) and plug-in hybrid electric vehicle penetration in the Core Countries is expected to grow 26 times to 13 million BEVs by 2030, reaching 3 million by 2025, and (ii) the “on-the-go” fast charging demand is expected to grow 46 times to 9 TWh by 2030, and up to 1.9 TWh by 2025. Charging System Operators and Charging Point Operators will take center stage in this market, and the role of owner and operator would represent the most attractive long-term opportunity in public fast charging market.
Given the size of this potential market, the Atlante Project has the ambition of developing, over the next 10 years, in line with what announced by Stellantis at the EV Day 2021 held on July 8, 2021:
- by 2025: charging stations in over 1,500 sites, with c.5,000 VGI Fastchargers integrated with storage and solar in the Core Countries (“Phase 1 ”); and
- by 2030: charging stations in c.9,000 sites, with over 35,000 VGI Fastchargers integrated with storage and solar in the Core Countries (“Phase 2 ”).
Perimeter and ambition
The Atlante Network will follow stringent unique technical features:
- fastcharging technology up to 200kW power , tailored to the “on-the-go” customer charging needs of max 15-30 min, with a unique centralized station setup to facilitate cost-effective and progressive scaling up of charging units over time. Charging stations will be equipped with canopies for convenient charging and parking.
- charging stations fully integrated in iconic local microgrids, with storage solutions and renewable energy sources to optimize charging costs and vehicle-to-grid integration services, that depending on sites’ configuration will include: (i) batteries with over 100kWh capacity to facilitate VGI services, (ii) second-life-batteries to ensure cost effective setup; (ii) additional renewable energy source through solar panels integrated in the canopies;
- All connected together , operating as a single aggregate of distributed energy and capacity resources, controlled and managed centrally providing grid services to European Transmission and Distribution System Operators (“Virtual Power Plant ”). Accordingly, the Atlante Network could in due course become the largest Virtual Power Plant ever built as of today, powering advanced VGI and behind-the-meter services to improve the fast charging business case, including: (i) basic VGI services with behind-the-meter off-peak charging or peak shaving to reduce electricity costs; (ii) advanced VGI services with in-front of the meter energy trading and grid balancing through at scale microgrid networks; (iii) self-consumption of solar photo-voltaic supporting low-cost electricity sourcing.
The main goals of the Atlante Project will be to reach market leader levels with:
- achieving a sizeable market share of around 15% market share in public “on-the-go” fast charging, in size and customers, across the Core Countries, in order to secure a sustainable long-term positioning. Indeed, market relevance and scale attract customers and reinforce utilization of network, while a large network with steady pipeline of locations and installations reduces operational and capital costs.
- an excellent customer charging experience through tailored charging offering with relevant charging speeds, price offering (e.g. with loyalty programs), and station infrastructure; and
- strategic charging sites across all Core Countries with at least one station per 100 km of highway and strategic non-highway sites to provide coverage to daily on-the-go customer needs.
ATLANTE go-to-market strategy
The Atlante Network will be developed at strategic locations across the Core Countries, by setting up the charging stations following three strategic criteria:
- Highway Charging: directly next to or near highway entrance/exit every 100-150 km, with ultra-fast charging speeds, specific for charging for long-distance drives;
- Off-Highway Charging: in urban areas, at traffic hot spots or at retailers, specific for charging for shorter drives, with fast to ultra-fast charging speed depending on local customer needs;
- Hybrid Charging: in other selected locations or premium sites in densely populated urban areas, i.e. between “on-the-go charging ” and "destination charging ”.
Project Atlante is structured in two phases, and all investments, expected to range over the period between 100 and 140 thousand euros per VGI Fastcharger integrated with storage and solar, will be made through a dedicated vehicle named “AtlanteCo ”. AtlanteCo will be initially owned 100% by NHOA and funded with its own resources and other forms of financing including, among others, TCC’s support as key founding investor.
PHASE 1 – 2022 to 2025
Phase 1 of the Atlante Network would start from Italy and France in 2022, scaling up to Spain and Portugal from 2023, and would be focused on:
- securing as many strategic sites as possible at minimal configuration to scale up at low cost securing the market positioning for the scale-up through 2030; and
- optimize technology setup to scale up rapidly through a centralized station approach, with up to 200kW chargers with VGI services.
PHASE 2 – 2026 to 2030
Phase 2 of the Atlante Network would be focused on rapidly gaining market share through scaling up stations and securing new sites. In particular:
- a modular setup will allow for cost-effective scale up as increasingly more 200kW chargers will be connected to centralized station approach as BEV charging speeds increase; and
- the use of growing scale in VGI will allow to move into more advanced grid services (e.g. grid balancing) to optimize charging use case,
targeting a 15% market share in the Core Countries, and such critical mass is expected to support the mid double-digit unlevered IRR target.
Project Atlante key industrial competences and partners
In order to reach the market goals and financial targets outlined above, the Atlante Project will have to leverage on:
-
specific technologies, know-how and industrial capabilities:
- a full suite of e-mobility products, services and technologies, including VGI technology and electrified mobility service provider capabilities, that will be provided by Free2Move eSolutions; and
- microgrids, energy storage and grid interconnection technology, including electrical system integration, engineering, procurement, construction and project development capabilities, that will be provided by NHOA.
In this respect, in its capacity as preferred turn-key technology provider, Free2Move eSolutions will act as preferred general contractor towards AtlanteCo, leveraging on the competencies of all the partners in the project, and above all, on the NHOA’s system integration, engineering, procurement, construction and project development capabilities.
- a wide network coverage and quick access to strategic charging locations, that will be identified with the support of Stellantis, also involving its dealership network and other partners, particularly in the first 18 months in light of the complexity and timing to account for sites’ planning and ability to achieve agreement on terms for use; and
- a broad customer base, with Stellantis’ ability to offer customer loyalty programs for Stellantis customers and ensuring a high level of utilization rate in the market for the Atlante Network.
- significant financial resources that NHOA has the intention to source, starting with the 50 million dollars funding that it has already secured and an additional 130 million euro from a potential capital increase as outlined in the Masterplan10x and the Strategic Ambitions released on the date hereo.
Project Atlante execution
As outlined in the Masterplan10x and the Strategic Ambitions released by NHOA on the date hereof, Project Atlante will be part of the Trading and Operational Updates released quarterly by NHOA. Quarterly performance indicators for the Atlante Project are expected to be (i) utilization rate of the Atlante network, (ii) number of sites, fastchargers and microgrids online, (iii) site pipeline update and (iv) conversion rate.
NHOA
NHOA develops technologies enabling the global transition towards clean energy and sustainable mobility, shaping the future of a next generation living in harmony with our planet.
Listed on Euronext Paris regulated market (NHOA:PA), NHOA forms part of the CAC® Mid & Small and CAC® All-Tradable financial indices. Its registered office is in Paris, with research, development and production located in Italy.
For further information, go to www.nhoa.energy .
Free2Move & Free2Move e-Solutions
Free2Move is a global mobility brand offering a complete and unique ecosystem for its private and professional customers around the world. Relying on data and technology, Free2Move puts the customer experience at the heart of the business to reinvent mobility and facilitate the transition to e-mobility.
Free2Move eSolutions is a joint venture between Stellantis and Engie EPS, aiming to become a leader in the design, development, manufacturing and distribution of electric mobility products. In a spirit of innovation and as a pioneer, the company will guide the transition to new forms of electric mobility, to contribute to the depletion in CO2 emissions.
Visit us on our websites: www.free2move.com/ , www.esolutions.free2move.com/
Follow us on LinkedIn
Follow us on Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20210722006070/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release
~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
